Management will initiate the session shortly after the market closes at 4:15 p.m. ET. Following a presentation of the quarterly performance, the company will open the floor for a question-and-answer period. Interested investors are encouraged to register online to receive specific dial-in instructions, though toll-free and international phone lines remain available for those without internet access.
Aethlon Medical Sets August 13 Date for First Quarter Earnings Call
San Diego-based Aethlon Medical will report its fiscal first-quarter financial results on August 13, 2026. The company, which specializes in the Hemopurifier immunotherapeutic device, plans to host a conference call at 4:30 p.m. ET to discuss the figures and provide updates on recent corporate developments.
Aethlon Medical continues to focus on its proprietary lectin-based technology, specifically the Hemopurifier, which holds FDA Breakthrough Device designation for treating advanced metastatic cancer and certain life-threatening viral infections. A replay of the conference call will be accessible on the company website and via designated phone lines starting one hour after the event concludes, remaining available through September 13, 2026.
Comments (0)
No comments yet. Be the first!